Daily Oral Medication

Obesity or Overweight, with or without Type 2 Diabetes

Locations: Long Island City, Queens (36-36 33rd Street)

Cost to you: none for study visits, tests, or study medication

Questions: 516-574-9232 · Hablamos español

Study to Investigate the Efficacy and Safety of a Once Daily Oral Medication in Adult Participants with Obesity or Overweight, with or without Type 2 Diabetes.
- At least 18 years of age
- Without Type 2 diabetes: BMI of 30 or more; or BMI of 25 to under 30 with at least one of hypertension, prediabetes, dyslipidemia, cardiovascular disease, or obstructive sleep apnea (BMI 25 to under 27 also needs a waist-to-height ratio of 0.5 or more)
- With Type 2 diabetes: BMI of 25 or more (BMI 25 to under 27 also needs a waist-to-height ratio of 0.5 or more), and either an established Type 2 diabetes diagnosis treated with diet and exercise or glucose-lowering medication other than a GLP-1 medication in the past 90 days, or HbA1c of 6.5% or more at screening
Gain access to cutting-edge medications and treatments before they are widely available.
Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.
We are highly focused on patient well-being and the highest ethical standards in clinical research.